COMMUNIQUÉS West-GlobeNewswire

Ultragenyx to Host Conference Call for Third Quarter 2026 Financial Results and Corporate Update
27/10/2026
NOVATO, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra- [...]
Cardiff Oncology Appoints Leila Alland, MD, as Interim Chief Medical Officer
27/10/2026
Seasoned oncology executive brings extensive clinical development expertise and a track record of advancing innovative cancer therapies SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF [...]
Adlai Nortye Announces Oral Presentation for AN4035 Program Update at the Upcoming 38th EORTC-NCI-AACR Symposium
27/10/2026
AN4035 late-breaking abstract selected for an oral presentation at the upcoming ENA Symposium in Barcelona Oral presentation will include translational and EGFR combination data for first-in-class AN4035 AN4035 is a [...]
OrthoPediatrics Corp. Reports Third Quarter 2026 Financial Results and Increases 2026 Financial Guidance
27/10/2026
Record Third Quarter 2026 Revenue of $72.7 Million , Up 19% Year-over-Year WARSAW, Ind., Oct. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused [...]
PacBio to Participate in Upcoming Investor Conferences
27/10/2026
MENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the [...]
OrthoPediatrics Announces FDA 510(k) Clearance of PNP | Femur Retrograde Nail System and Completes First Implantations
27/10/2026
New addition to the Pediatric Nailing Platform expands options for pediatric femoral trauma and deformity correction WARSAW, Ind., Oct. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the " [...]
Revolution Medicines to Participate in November 2026 Investor Conferences
27/10/2026
REDWOOD CITY, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for [...]
Outset Medical to Participate in the 2026 Stifel Healthcare Conference
27/10/2026
SAN JOSE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
TELA Bio to Announce Third Quarter 2026 Financial Results
27/10/2026
MALVERN, Pa., Oct. 27, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
The Ensign Group Reports Third Quarter 2026 Results; Raises 2026 Annual Earnings Guidance
27/10/2026
Conference Call and Webcast scheduled for tomorrow, October 28, 2026 at 10:00 am PT SAN JUAN CAPISTRANO, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign [...]
PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026
27/10/2026
DELRAY BEACH, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the second quarter fiscal year [...]
Chemed Reports Third-Quarter 2026 Results
27/10/2026
CINCINNATI, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and Roto-Rooter , the [...]
CooperCompanies Announces Leadership Transition and Board Refreshment
27/10/2026
Independent Director and Seasoned Healthcare Executive Walt Rosebrough Elected Executive Chair; Search for CEO Underway Provides Update on Board Refreshment, Including Planned Addition of Medical Device and Vision [...]
DBV Technologies présente ses résultats financiers du troisième trimestre 2026 et fait le point sur ses activités
27/10/2026
Châtillon, France, le 27 octobre (22 :30 CEST) 2026 DBV Technologies présente ses résultats financiers du troisième trimestre 2026 et fait le point sur ses activités DBV La Société organise une conférence téléphonique [...]
DBV Technologies to Report Third Quarter 2026 Financial Results and Business Update on October 28, 2026
27/10/2026
Châtillon, France, October 27, 2026 DBV Technologies to Report Third Quarter 2026 Financial Results and Business Update on October 28, 2026 Company to host investor conference call and webcast at 5:00pm ET DBV [...]
Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026
27/10/2026
CARLSBAD, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced [...]
Rapport Announces Proposed Public Offerings of Common Stock and Convertible Notes as well as Concurrent Private Placement
27/10/2026
BOSTON and SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
Northwestern Medicine establishes a Transplant Institute focused on innovation and access
27/10/2026
The Northwestern Medicine Transplant Institute launches on the heels of surgeons performing Northwestern Medicine’s 3,000th liver transplant B-roll, photos and interview: https://www.dropbox.com/scl/fo/ [...]
Ossium Health CEO Kevin Caldwell Wins 2026 Biocom Catalyst Award
27/10/2026
SAN FRANCISCO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Kevin Caldwell, Ossium Health CEO, Co-Founder & President, has been named a winner of the 2026 Biocom Catalyst Award. Now in its 11th year, the Catalyst Awards honor [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum